Search filters

Filters
Clear All

Phase

  • 1
  • 1
  • 1
  • 5
  • 9
  • 5
  • 9

Found 9 Brain Tumor trials

A listing of Brain Tumor medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
99 years or below
All genders
This study will assess the ex vivo use of established and in-house near-infrared fluorophores for imaging brain tumors. Fluorophores will be topically applied to freshly excised tumor specimens for imaging on the surgical back table. Participants are patients undergoing surgery for CNS tumors who consent to use of their specimens. …
UPCC 09321 Whole-Brain Spectroscopy Guided Personalized Mapping Of Transducer Arrays For Glioblastoma Patients Receiving Tumor Treating Fields
22 years or above
All genders
Interventional
This study investigates the effectiveness of personalized mapping techniques for patients with Glioblastoma, a type of brain cancer. The purpose of this study is to compare two different mapping methods used in tumor treating fields (TTFields) therapy, which is a type of electrical therapy that has shown to improve survival …
UPCC 20319 GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
18 years or above
All genders
Phase 2/3
Interventional
This study investigates therapies for glioblastoma, a type of brain cancer. The purpose of this study is to evaluate multiple therapies for newly diagnosed and recurrent glioblastoma using a response adaptive randomization platform. This method assigns participants to different study arms based on their performance, aiming to identify effective treatments …
18 years or above
All genders
Phase 1
Interventional
This study investigates the safety of using a type of immune cell therapy in patients with glioblastoma. The study will use T cells, which are a type of white blood cell, that have been modified to target specific proteins on cancer cells. These proteins are known as EGFR and IL13Ra2. …
99 years or below
All genders
PURPOSE We would like to accrue patients consecutively over a several year period in order to collect tissue from many histopathologic subsets of nervous system tumors. Primary brain tumors occur nationally at a rate of approximately 17,000 new cases annually and within this group there are numerous subtypes. At the …
18 years or above
All genders
Phase 2
Interventional
This study investigates progressive meningiomas. It looks at how certain investigational medications work for people with this condition.The focus is on evaluating the safety and effectiveness of these investigational medications. The study will see how these medications impact the condition in general.Who can participate: Adults with progressive or residual meningiomas …
99 years or below
All genders
The primary objective is to collect specimens and information about subjects with sinonasal tumors for inclusion in the CHOP Children's Brain Tumor Tissue Consortium (CBTTC) Repository. Bank tumor specimens from sinonasal cancer patients n/a
99 years or below
All genders
A multi-center non-randomized, single-arm feasibility trial to build and validate technology platform to collect, analyze and co-register multi-modal data across time and sites. Patients will undergo standard of care therapy for brain tumor diagnosis. Patients will be assessed pre- and post-operatively using neuropsychological tests for language function and mental health. …
UPCC 21317 Detection of Cell-Free Circulating Tumor DNA in Patients with Histopathologically/Molecularly Proven or Radiographically Suspected Glial Tumors
99 years or below
All genders
Glioblastoma (GBM) is the most common primary brain tumor in adults and is uniformly fatal. During standard adjuvant treatment for GBM following initial surgical resection of the tumor, patients are treated with a combination of radiation and chemotherapy. During and after this adjuvant treatment, patients are monitored for disease progression …